On the Record · Diplomat Pharmacy
Diplomat Pharmacy acquisitions, on the record
The businesses Diplomat Pharmacy bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
MedPro Rx, Inc. ("MedPro")Word for word“In June 2014, we acquired MedPro Rx, Inc. (“MedPro”), a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin.” 10-K for 2016 | acquisition | June 2014 | — |
BioRx, LLC ("BioRx")Word for word“In April 2015, we acquired BioRx, LLC (“BioRx”), a highly specialized pharmacy and infusion services company that provides treatments for patients with ultra-orphan and rare, chronic diseases.” 10-K for 2016 | acquisition | April 2015 | — |
Burman’s Apothecary, LLC ("Burman’s")Word for word“In June 2015, we acquired Burman’s Apothecary, LLC (“Burman’s”), a provider of individualized patient care with a primary focus on hepatitis C.” 10-K for 2016 | acquisition | June 2015 | — |
Valley Campus Pharmacy, Inc. doing business as TNH Advanced Specialty Pharmacy ("TNH")Word for word“On June 1, 2016, we acquired all of the outstanding equity interests of TNH for a total acquisition price of $78,422, excluding related acquisition costs.” 10-K for 2016 | acquisition | June 1, 2016 | $78,422 |
compounding businessWord for word“the loss of non-specialty dispenses resulting from the sale of our compounding business in September 2015, and a business decision to exit dispensing certain high-volume, but low-profit, drugs.” 10-K for 2016 | divestiture | September 2015 | — |
American Homecare Federation, Inc.Word for word“Organic growth has been paramount since we were founded, but we have completed five important acquisitions in recent years: American Homecare Federation, Inc. (December 2013); MedPro (June 2014); BioRx (April 2015); Burman’s (June 2015); and TNH (June 2016).” 10-K for 2016 | acquisition | December 2013 | — |
LDI Holding Company, LLC (LDI Integrated Pharmacy Services)Word for word“On December 20, 2017, we acquired LDI Holding Company, LLC, doing business as LDI Integrated Pharmacy Services (“LDI”) for a total acquisition price of $600,388, excluding related acquisition costs.” 10-K for 2017 | acquisition | On December 20, 2017 | $600,388 |
Pharmaceutical Technologies, Inc. (National Pharmaceutical Services)Word for word“On November 27, 2017, we acquired Pharmaceutical Technologies, Inc., doing business as National Pharmaceutical Services (“NPS”), for a total acquisition price of $47,190, excluding related acquisition costs.” 10-K for 2017 | acquisition | On November 27, 2017 | $47,190 |
Focus Rx Pharmacy Services Inc. and Focus Rx Inc. (Focus)Word for word“On September 1, 2017, we acquired Focus Rx Pharmacy Services Inc. and Focus Rx Inc. (collectively, “Focus”) for a total acquisition price of $24,975, excluding related acquisition costs.” 10-K for 2017 | acquisition | On September 1, 2017 | $24,975 |
Accurate Rx Pharmacy Consulting, LLC (Accurate)Word for word“On July 5, 2017, we acquired Accurate Rx Pharmacy Consulting, LLC (“Accurate”) for a total acquisition price of $13,164, excluding related acquisition costs.” 10-K for 2017 | acquisition | On July 5, 2017 | $13,164 |
WRB Communications, LLC (WRB)Word for word“On May 8, 2017, we acquired WRB Communications, LLC (“WRB”) for a total acquisition price of $31,625, excluding related acquisition costs.” 10-K for 2017 | acquisition | On May 8, 2017 | $31,625 |
Comfort Infusion, Inc. (Comfort)Word for word“On March 22, 2017, we acquired Comfort Infusion, Inc. (“Comfort”) for a total acquisition price of $14,413, excluding related acquisition costs.” 10-K for 2017 | acquisition | On March 22, 2017 | $14,413 |
Affinity Biotech, Inc. (Affinity)Word for word“On February 1, 2017, we acquired Affinity Biotech, Inc. (“Affinity”) for a total acquisition price of $17,412, excluding related acquisition costs.” 10-K for 2017 | acquisition | On February 1, 2017 | $17,412 |
LDI Holding Company, LLC, doing business as LDI Integrated Pharmacy Services ("LDI")Word for word“In late 2017, we entered the PBM business through our December 2017 acquisition of LDI Holding Company, LLC, doing business as LDI Integrated Pharmacy Services (“LDI”) and our November 2017 acquisition of Pharmaceutical Technologies, Inc., doing business as National Pharmaceutical Services (“NPS”).” 10-K for 2018 | acquisition | December 2017 | — |
Pharmaceutical Technologies, Inc., doing business as National Pharmaceutical Services ("NPS")Word for word“In late 2017, we entered the PBM business through our December 2017 acquisition of LDI Holding Company, LLC, doing business as LDI Integrated Pharmacy Services (“LDI”) and our November 2017 acquisition of Pharmaceutical Technologies, Inc., doing business as National Pharmaceutical Services (“NPS”).” 10-K for 2018 | acquisition | November 2017 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) |
|---|---|
| 2016-12-31 | $12.6 million |
| 2017-12-31 | $3.5 million |
| 2018-12-31 | $13.1 million |
Deal filings since 2016
- 2020-02-10 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2019-12-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-08-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-12-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-12-21 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2017-11-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-04-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-10-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Diplomat Pharmacy’s annual reports (10-K for 2018, 10-K for 2017, 10-K for 2016) and the financial data it files with the SEC, as of 2019-03-18. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.